Brief history {#sec1}
=============

A 53-year-old woman with newly diagnosed acute myeloid leukemia (AML) developed a new pruritic, papular eruption approximately 1 week after initiation of induction chemotherapy with daunorubicin and cytarabine. The rash started on her back and progressed to involve the neck, chest, abdomen, and extremities. The patient had persistent neutropenic fevers of unknown etiology and began treatment with cefepime 2 days before the rash developed. She also complained of drenching night sweats. On physical examination, numerous pink edematous papules were scattered across the back, lateral aspects of the neck, chest, abdomen, and extremities ([Figs 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). Punch biopsy of a left thigh lesion was performed ([Fig 3](#fig3){ref-type="fig"}).Fig 1Fig 2Fig 3

**What is the diagnosis?**A.Leukemia cutisB.Transient acantholytic dermatitisC.Neutrophilic eccrine hidradenitisD.Drug-induced hypersensitivity syndromeE.Acute febrile neutrophilic dermatosis

**Click** [here](https://digital-catalog.aad.org/diweb/catalog/launch/package/4/did/373642/iid/373642){#intref0010} **to view disclosures, take the quiz, and claim CME credit.**
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